Ray Dalio Jazz Pharmaceuticals PLC Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 112,999 shares of JAZZ stock, worth $13.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

112,999

Previous 101,135 11.73%

Holding current value

$13.9 Million

Previous $10.8 Million 16.68%

% of portfolio

0.07%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.57 - $116.37 $1.19 Million - $1.38 Million	11,864 Added 11.73%	112,999 $12.6 Million
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $899,704 - $1.03 Million	-8,656 Reduced 7.88%	101,135 $10.8 Million
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $2.23 Million - $2.57 Million	19,375 Added 21.43%	109,791 $13.2 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $301,646 - $359,040	2,640 Added 3.01%	90,416 $11.1 Million
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $9.35 Million - $11.1 Million	76,599 Added 685.33%	87,776 $11.4 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $1.37 Million - $1.64 Million	11,177 New	11,177 $1.39 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $3.22 Million - $3.97 Million	-24,850 Reduced 88.05%	3,373 $537,000
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $3.57 Million - $4.55 Million	28,223 New	28,223 $3.76 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $263,714 - $320,474	-2,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $283,007 - $406,538	2,200 New	2,200 $286,000
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $338,678 - $391,242	-2,255 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $317,301 - $372,187	2,255 New	2,255 $372,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account